Lerifen A 5mg/75mg Tablet
Marketer
Phenomax Pharmaceuticals
Salt Composition
Levocetirizine (5mg) + Ambroxol (75mg)
Overview Lerifen A 5mg/75mg Tablet
Combiflu-A 5mg/75mg tablets are a dual-action medication for cough management. This formulation addresses allergic symptoms like sneezing, nasal discharge, eye watering, itching, swelling, and nasal congestion. It also facilitates mucus thinning and expectoration, easing cough expulsion. Combiflu-A 5mg/75mg tablets are administered with or without food, as directed by your physician, with dosage dependent on individual response and condition severity. Continue treatment as prescribed; premature cessation may lead to symptom recurrence and condition exacerbation. Inform your doctor of all concurrent medications, as interactions are possible. Common side effects include nausea, dry mouth, headache, tiredness, and allergic reactions; most are transient. Report any concerning side effects immediately. Drowsiness and dizziness are potential effects; avoid driving or tasks requiring concentration until effects are known. Alcohol consumption should be avoided due to potential exacerbation of dizziness. Self-medication and recommending this medication to others are strictly prohibited. Adequate hydration is recommended. Prior to use, disclose any liver or kidney conditions to your doctor. Pregnant or lactating individuals should seek medical counsel before using this medication.
Uses of Lerifen A 5mg/75mg Tablet
Respiratory irritation
Major Benefits of Lerifen A 5mg/75mg Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Lerifen A 5mg/75mg Tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Lerifen A 5mg/75mg Tablet:
- Upset stomach
- Dryness in mouth
- Headache
- Fatigue
- Sleepiness
- Allergic reaction
How to use Lerifen A 5mg/75mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the 5mg/75mg Lerifen A tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be independent of them, though consistent timing is recommended.
How Lerifen A 5mg/75mg Tablet works:
Each Lerifen A tablet (5mg/75mg) contains a dual-action medication blend.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Lerifen A 5mg/75mg tablets and alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Lerifen A 5mg/75mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Lerifen A 5mg/75mg tablets with breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking a Lerifen A 5mg/75mg tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with impaired kidney function should use Lerifen A 5mg/75mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Lerifen A 5mg/75mg tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Lerifen A 5mg/75mg tablets. Dosage modifications for Lerifen A 5mg/75mg tablets may be necessary. Physician consultation is recommended.
What if you forget to take Lerifen A 5mg/75mg Tablet :
Should you forget a Lerifen A 5mg/75mg Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Lerifen A 5mg/75mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Breathing |
3,018 People bought this recently